Observational study on intracerebral hemorrhage in hospitalized adults
A Prospective Observational Cohort Study in Chinese Patients With Primary Intracerebral Hemorrhage
This study is trying to learn more about adults in the hospital with brain bleeding to better understand their treatment options and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 856 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT04707105 on ClinicalTrials.gov |
What this trial studies
This study aims to gather contemporary data on the prevalence, characteristics, risk factors, and prognosis of hospitalized adult patients in China suffering from primary intracerebral hemorrhage (ICH). It is a prospective, observational cohort study that will analyze various aspects of ICH, including treatment approaches and cost-effectiveness. The goal is to enhance understanding of this serious condition, which has high mortality rates and limited effective treatments. By focusing on a specific patient population, the study seeks to provide valuable insights into ICH management.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized adults over 18 years old diagnosed with primary intracerebral hemorrhage.
Not a fit: Patients with secondary intracerebral hemorrhage or those who cannot undergo necessary assessments will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and treatment strategies for patients with intracerebral hemorrhage.
How similar studies have performed: While there have been studies on intracerebral hemorrhage, this specific observational approach focusing on the Chinese population may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized patients over 18 years old of primary intracerebral hemorrhage. Exclusion Criteria: 1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor. 2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients； 3. surgical evacuation of hematoma； 4. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI 5. patients cannot be followed up for any reasons. 6. patients death in 24 hours 7. pregnant patients
Where this trial is running
Hangzhou, Zhejiang
- 2nd Affiliated Hospital, School of Medicine at Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Feng Gao, MD,PhD — Second Affiliated Hospital, School of Medicine, Zhejiang University
- Study coordinator: Feng Gao, MD,PhD
- Email: 2202012@zju.edu.cn
- Phone: 13588451471
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.